# Ata Aed Ddavp Monitoring

> This skill recommends monitoring desmopressin (DDAVP) doses and adjusting them as needed in patients who have recently started antiepileptic drugs (AEDs). It is triggered when a patient initiates AED therapy and requires DDAVP management for diabetes insipidus.

- Skill: `dromlakhani/ata-aed-ddavp-monitoring` (Agent Skill)
- Install (CLI): `npx skillmds add dromlakhani/ata-aed-ddavp-monitoring`
- Raw SKILL.md: https://api.skillmd.com/api/skills/dromlakhani/ata-aed-ddavp-monitoring/raw
- Safety review: pending (external: skill-scanner PASS, skillspector PASS)
- Works with: Claude Code, Claude.ai, OpenAI Codex
- Category: Coding & Dev Tools
- Author: dromlakhani (https://skillmd.com/u/dromlakhani)
- Updated: 2026-08-19
- Page: https://skillmd.com/skills/dromlakhani/ata-aed-ddavp-monitoring

---


# Monitor desmopressin doses and adjust as needed in patients started on antiepileptic drugs

## STEP 1 — Gather Information
Collect current DDAVP dose, frequency, and route; assess for polyuria, nocturia, or signs of dehydration; measure serum sodium and weight; review AED type and start date.

## STEP 2 — Rule In / Rule Out
Check serum sodium: if <135 mmol/L, rule in over-replacement; if ≥135 mmol/L, rule out over-replacement and assess for polyuria (>3L/24h) or nocturia.

## STEP 3 — Classify or Stratify
If polyuria or nocturia present, classify as under-replacement; if asymptomatic with normal serum sodium, classify as adequate replacement.

## STEP 4 — Decide
For over-replacement, decrease DDAVP dose by 10-20%; for under-replacement, increase dose by 10-20%; for adequate, maintain current dose and schedule re-evaluation in 1 week.

## Clinical Guardrails / Mimics / Pitfalls
Avoid abrupt DDAVP dose changes to prevent rapid shifts in serum sodium; monitor serum sodium and weight 2-3 times weekly after AED initiation; do not use DDAVP in patients with impaired thirst mechanism without close supervision; educate patients to recognize polyuria (under-replacement) versus headache/nausea (over-replacement).

## Concrete Clinical Example
A 45-year-old woman with central diabetes insipidus on DDAVP 10 mcg nasally twice daily starts carbamazepine for new-onset seizures; after 4 days, she reports increased nocturia and polyuria (4L/24h), serum sodium 138 mmol/L, weight stable; skill classifies as under-replacement, decides to increase DDAVP to 15 mcg nasally twice daily; after 48 hours, nocturia decreases to 1-2 episodes/night and polyuria resolves.

**Source:** Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, 10.1210/jc.2016-2118